Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia

Abstract

Since December 2019, multiple cases of novel coronavirus pneumonia (NCP) have been identified in Wuhan, Hubei. With the spread of the epidemic, such cases have also been found in other parts of China and abroad. As an acute respiratory infectious disease, NCP has been included in class B infectious diseases prescribed in the Law of the People's Republic of China on Prevention and Treatment of Infectious Diseases, and managed as an infectious disease of class A. With a better understanding of the epidemic and accumulation of diagnosis and treatment experience, we now release the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (Trial Version 6), which is based on the fifth trial version.